Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hemichannel extracellular-domain specific agents for treating sepsis

Hemichannel extracellular-domain specific agents for treating sepsis

US Patent 10548949 · Granted Feb 4, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AAV capsids for targeting nervous system and uses thereof2025
Hepatitis B antiviral agents2025
Tetranectin-targeting monoclonal antibodies to fight against lethal sepsis and o2025
Nerve stimulation for treatment of diseases and disorders2025
Spiropyrrolidine derived antiviral agents2025
Manufacture of compounds and compositions for inhibiting the activity of SHP22025
Macrocyclic spiropyrrolidine derived antiviral agents2025
Metabolically stable pyrimidinyl dihydroquinoxalinones as tubulin polymerization2025
Recombinant adeno-associated viral vectors for treating Bietti Crystalline Dystr2025
Biodegradable ultra-pH sensitive polymers2025
Motor locking mechanism including memory alloy wire2025
Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhib2025